PCN19 Effectiveness and Medical Costs of Abiraterone Acetate Versus Docetaxel in First-LINE Treatment of Metastatic Castration-Resistant Prostate Cancer from the French Nationwide Claims Database (SNDS): Camerra Study
Dec 1, 2020, 00:00 AM
10.1016/j.jval.2020.08.156
https://www.valueinhealthjournal.com/article/S1098-3015(20)32412-8/fulltext
Section Title :
Section Order :
10115
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32412-8&doi=10.1016/j.jval.2020.08.156